U.S. Pharmaceutical Market (2025 - 2030) Size, Share & Trends Analysis Report By Molecule (Biologics & Biosimilars, Conventional Drugs), By Product, By Type, By Route Of Administration, By Disease, By Age Group, By Distribution Channel, And Segment Forecasts

Market Segmentation

U.S. Pharmaceutical Molecule Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Biologics & Biosimilars (Large Molecules)
  - Monoclonal Antibodies
  - Vaccines
  - Cell & Gene Therapy
  - Others
- Conventional Drugs (Small Molecules)
U.S. Pharmaceutical Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Branded
- Generic
U.S. Pharmaceutical Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Prescription
- OTC
U.S. Pharmaceutical Disease Outlook (Revenue, USD Billion, 2018 - 2030)
- Cardiovascular diseases
- Cancer
- Diabetes
- Infectious diseases
- Neurological disorders
- Respiratory diseases
- Autoimmune diseases
- Mental health disorders
- Gastrointestinal disorders
- Women’s Health Diseases
- Genetic and Rare genetic diseases
- Dermatological conditions
- Obesity
- Renal diseases
- Liver conditions
- Hematological disorders
- Eye conditions
- Infertility conditions
- Endocrine disorders
- Allergies
- Others
U.S. Pharmaceutical Route of Administration Outlook (Revenue, USD Billion, 2018 - 2030)
- Oral
  - Tablet Capsule
  - Suspensions
  - Other
- Topical
- Parenteral
  - Intravenous
  - Intramuscular
- Inhalations
- Other
U.S. Pharmaceutical Age Group Outlook (Revenue, USD Billion, 2018 - 2030)
- Children & Adolescents
- Adults
- Geriatric
U.S. Pharmaceutical Distribution Channel Group Outlook (Revenue, USD Billion, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments